tobramycin/dexamethasone / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 30 Diseases   7 Trials   7 Trials   149 News 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tobramycin/dexamethasone / Generic mfg.
2016-004416-35: Comparative study of different therapeutic regimens based on tobramycin, dexamethasone and diclofenac for the prevention of macular edema after cataract surgery. Estudio comparativo de diferentes pautas terapéuticas basadas en tobramicina, dexametasona y diclofenaco para la prevención del edema macular post cirugía de catarata.

Ongoing
4
210
Europe
Ear/eye drops, solution, Eye drops, solution, Eye drops, Tobrex 3 mg/ml, COLIRCUSÍ DEXAMETASONA 1 mg/ml, Diclofenaco-Lepori, tobradex
Fundació Parc Taulí, Fundació Parc Taulí
Pseudophakic macular edema is a pathology that results from cataract surgery, usually occurring 4-6 weeks after surgery, which directly affects the retina (specifically the macula, the region that provides maximum visual acuity). In this condition, for different reasons, an inflammatory exudate accumulates in the different layers of the retina and can lead to affect the visual acuity, to severe retinal alterations both acute or chronic. El edema macular pseudofáquico es una patología derivada de la cirugía de cataratas que ocurre generalmente entre las 4-6 semana posterior al acto quirúrgico, que afecta directamente a la retina (específicamente la mácula, región que brinda la máxima agudeza visual). En esta condición, por diversos mecanismos se acumula un exudado inflamatorio en las distintas capas de la retina que puede llevar a afectar la agudeza visual, hasta alteraciones retinianas mas severas tanto agudas como crónicas., Pseudophakic macular edema is a condition that can occur postoperatively in cataract surgery consisting on fluid accumulation in the retina. El edema macular pseudofáquico es una condición que puede ocurrir en el postoperatorio de la cirugía de cataratas que consiste en la acumulación de líquido en la retina., Diseases [C] - Eye Diseases [C11]
 
 
ChiCTR-IIR-17012663: Effect of Mingmu Xunxi Decoction on Meibomian gland dysfunction: a randomized-controlled clinical trail

Not yet recruiting
4
118
 
application of Mingmu Xunxi Decoction for 1m ;Meibomian glands massage, application of the tobramycin dexamethasone eye ointment per night, application of artificial tear drops 4-8 times pei day
Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region; Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Natural Science Foundation of Xinjiang Uygur Autonomous Region
Meibomian gland dysfunction
 
 
ChiCTR1800015604: Etiology and treatment strategies for pediatric blepherokeratoconjunctivitis

Recruiting
4
80
 
0.3%tobramycin-0.1%dexamethasone ointment, OCuSOFT Plus Eyelid Cleanser ;0.3%tobramycin-0.1%dexamethasone ointment ;0.3% tobramycin ointment, OCuSOFT Plus Eyelid Cleanser ;0.3% tobramycin ointment
Peking Unversity Third Hospital; Peking University Third Hospital, Researcher funds
blepherokeratoconjunctivitis
 
 
NCT06404541: A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface

Active, not recruiting
4
60
RoW
Dexamethasone, tobramycin, netilimicin
Kasr El Aini Hospital
Ocular Surface Disease, Dry Eye Syndromes
04/24
05/24
ChiCTR-IIR-17014018: The clinical research of safety and effectiveness of Tobrdex (0.3% and 0.1% tobramycin dexamethasone ophthalmic suspension) as control, Zylet (0.5% loteprednol and 0.3% tobramycin ophthalmic suspension) treatment blepharo-keratoconjunctivitis

Completed
1
344
 
Zylet (0.5% loteprednol and 0.3% tobramycin ophthalmic suspension) ;Tobrdex (0.3% and 0.1% tobramycin dexamethasone ophthalmic suspension)
Eye Hospital of Wenzhou Medical University; Bausch & Lomb Limited by Share Ltd, company
blepharo-keratoconjunctivitis
 
 
NCT06175676: Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis

Completed
1
90
RoW
Hydroxybutyl chitosan, 5-Fluorouracil, Gelatin Sponge Sheet
Tianjin Medical University Eye Hospital
Dacryocystorhinostomy, Hydroxybutyl Chitosan, Fluorouracil, Chronic Dacryocystitis
06/23
12/23
NCT04624035: Implantable Phakic Lens (IPCL) VS Implantable Collamer Lens

Recruiting
N/A
60
RoW
Implantable Collamer Lens (ICL) in treatment of myopia in adults., All drugs used were mentioned in the arm description, Implantable Intraocular Lens (IPCL) in treatment of myopia in adults.
Assiut University
Myopia
01/21
10/21
NCT06200727: Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases

Active, not recruiting
N/A
170
RoW
PRF membrane tamponade surgery in macular hole, ILM peeling in macular hole, PRF membrane grafting in pterygium, Autologous conjunctival transplantation in pterygium, autologous PRF membrane grafting in trabeculectomy for glaucoma, Amniotic membrane in trabeculectomy for glaucoma, PRF membrane grafting incorneal ulcer, Amniotic membrane in corneal ulcer
Lei Du
Platelet-rich Fibrin, Macular Holes, Pterygium, Glaucoma
06/25
12/25
NCT04571788: Treating Rhegmatogenous Retinal Detachment by Foldable Capsular Buckle

Recruiting
N/A
150
RoW
Foldable Capsular Buckle, Silicone scleral padding
Aier School of Ophthalmology, Central South University
Rhegmatogenous Retinal Detachment, Surgery
12/21
12/21

Download Options